Pfizer identifies Synexus’ South African clinical research sites as INSPIRE sites – first in Africa 12 Jun 2013Three of Synexus' South African dedicated clinical research centres Stanza, Watermeyer and Nyeleti have been identified by Pfizer as meeting the exacting standards that the company demands to join a worldwide network of INSPIRE sites which must be both highly productive and effective.
Synexus strengthens its global management team 22 Apr 2013Dr Christophe Berthoux CEO of Synexus has spearheaded a complete overhaul of Synexus' management structure over the last two years. Its top team now better reflects its extensive global presence and its culture of professionalism and continuous improvement.
Since its launch 21 years ago Synexus has grown from a small clinic adjoining founder Dr Smith's surgery to the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its 25 clinics across Europe and Africa.
New Managing Director for Synexus Germany 28 Mar 2013
Klaus - Dieter Albrecht has been appointed Managing Director of Synexus Germany. Klaus is responsible for the management of the eight Synexus dedicated clinical trial centres in Germany including new business and profitability. Synexus, which is based in Manchester, is the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its own dedicated research centres.
Quality drives Synexus to be the first to initiate the revalidation of its research doctors and CQC registration of its clinics 05 Nov 2012Synexus has become one of the first clinical research companies to have both registered their five clinics in England with the Care Quality Commission and simultaneously registered as a designated body with the GMC to support the revalidation of its clinical research physicians.